Showing results (391-400 of 437) with videos related to
Sort By:
Pageof 44
The Journal of Clinical Investigation|May 20, 2009
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesionsMartin L Sos, Kathrin Michel, Thomas Zander, et al.Nature|February 11, 2011
The genomic complexity of primary human prostate cancerMichael F Berger, Michael S Lawrence, Francesca Demichelis, et al.The Journal of Clinical Investigation|December 22, 2012
Prognostically relevant gene signatures of high-grade serous ovarian carcinomaRoel G W Verhaak, Pablo Tamayo, Ji-Yeon Yang, et al.Cell Reports. Medicine|March 4, 2022
Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanomaSamuel S Freeman, Moshe Sade-Feldman, Jaegil Kim, et al.Cancer Discovery|April 30, 2021
FGFR2 Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in CholangiocarcinomaJames M Cleary, Srivatsan Raghavan, Qibiao Wu, et al.Cell|April 30, 2013
Punctuated evolution of prostate cancer genomesSylvan C Baca, Davide Prandi, Michael S Lawrence, et al.Nature|July 24, 2012
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutationsTrevor J Pugh, Shyamal Dilhan Weeraratne, Tenley C Archer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2020
Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast CancerHeather A Parsons, Justin Rhoades, Sarah C Reed, et al.Nature Genetics|November 5, 2013
Somatic mutation of CDKN1B in small intestine neuroendocrine tumorsJoshua M Francis, Adam Kiezun, Alex H Ramos, et al.Cell|September 18, 2012
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencingMarcin Imielinski, Alice H Berger, Peter S Hammerman, et al.Pageof 44